Insilico's AI-designed drug proves effective in treating lung disease
Longevity Technology - 20-Sep-2024Phase 2a trial results show positive outcomes among pulmonary fibrosis patients
Join the club for FREE to access the whole archive and other member benefits.
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
Dr. Zhavoronkov holds two bachelor degrees from Queen’s University, a master’s in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.
As at Sept-20: 313 Publications, 4,053 Citations
Prior to founding Insilico Medicine, he worked in senior roles at ATI Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI and established AgeNet.net competitions and diversity.AI initiative.
Author of "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy", Palgrave Macmillan, NY, 2013 - available in English, Japanese, Chinese, and Polish.
Visit website: http://www.agelessbook.com/the-author-details/
See also: Insilico Medicine - Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Details last updated 04-Jul-2019
27-Oct-2023 to 30-Oct-2023
Conference on Aging and Disease organized by International Society on Aging and Disease (ISOAD)
01-Sep-2020 to 04-Aug-2020
Latest progress in the molecular, cellular and organismal basis of aging
31-Aug-2021 to 03-Sep-2021
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
29-Aug-2022 to 02-Sep-2022
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
28-Aug-2023 to 01-Sep-2023
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
04-Feb-2021
NUS Healthy Longevity webinar with Alex Zhavoronkov - CEO of Insilico Medicine
25-Nov-2023
Conference promoting healthy longevity organised by Longevity Alliance Baltic (LAB) (Riga, Latvia, FREE)
07-Jun-2024 to 08-Jun-2024
Conference promoting healthy longevity organised by Longevity Alliance Baltic (LAB) (Riga, Latvia)
26-Mar-2021
AMA with Sergey Young, Alex Zhavoronkov and Sourav Sinha
06-Sep-2023 to 08-Sep-2023
A compelling lineup of speakers from all areas of the biology of ageing
Alex Zhavoronkov delivered a keynote on AI-Guided End-to-End Drug Discovery
05-Nov-2022 to 06-Nov-2022
Healthy Masters conference about living longer and healthier life
11-Nov-2023 to 12-Nov-2023
Healthy Masters conference about living longer and healthier life
19-Nov-2021
Ageing Research at King's (ARK) Longevity Week 2021 Event (FREE)
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
20-Apr-2023
1 hour virtual event organized by Deep Longevity with Alex Zhavoronkov and Deepankar Nayak
By Tina Woods - How artificial intelligence is helping us extend our healthspan and live better too
28-Sep-2022 to 30-Sep-2022
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth
27-Sep-2023 to 29-Sep-2023
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger, Dr. Tobias Reichmuth and Daniel Koetser
30-Aug-2021
Workshop is part of ARDD 2021 conference that brings health care providers involved in longevity, organized by Cassandra Coburn and Evelyne Bischof. (FREE)
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
24-Oct-2022
Online event about harnessing the power of AI to improve the discovery process for drugs by OSAL with Alex Zhavoronkov (FREE)
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
24-Jan-2024
Preliminary results and breakthroughs of RMR project by Longevity Education Hub
10-Oct-2022 to 13-Oct-2022
The Kitalys Institute virtual conference about going beyond treating individual diseases to extending healthy lifespan
The Ageless Generation by Alex Zhavoronkov is an engaging work that causes us to rethink our ideas of age and ability in the modern world
Phase 2a trial results show positive outcomes among pulmonary fibrosis patients
AI could cut preclinical drug development time by half, but rigorous trials are crucial
Experts discuss on the ethics and feasibility of body transplants in the near future
Using AI to screen natural compounds and create novel longevity products
Key points from Arkadi Mazin's summary of 5 days of talks by geroscientists and biotech leaders
Genetika+ tests drugs against a patient's own cells; Insilico Medicine is slashing the time taken for drug discovery
Big data combined with laboratory automation - the pace of drug discovery is about to take off!
With an accuracy of 4.7 years it is much more convenient for home testing
New collab with Teva Pharmaceuticals to identify drug targets for various diseases
Insilico's novel drug target is prepping for IND studies, expecting to start clinical studies by early 2022
More and more companies making greater and greater progress - 2021 could be an exciting year
Deep longevity's psychological clock might help you feel younger and live longer
Taisho and Insilico collabs to identify novel targets for senolytic drugs
An automated sense-check of publications sounds like a good idea
Apps such as Young. ai will play a key role in helping understand and reversing aging processes
Insilico Medicine is slashing the cost of drug development
Biological clocks are a moving target so they'll need other researchers to corroborate their analysis
LEAF summarises and exchange of thoughts between leading aging researchers
To benefit long term global health and longevity, and enhance economic recovery
From lab to clinic in 2 years instead of 10 would have a huge impact on health
AI-based methods, to explore mechanisms of ageing and improving health-span
It both affects and is affected by its host status
Groundbreaking research biotechs performs aging research together for longevity
Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...
Lifespan.io is launching a crowdfunding campaign to support MouseAGE. Software will assess visua...
We are at an inflection point for the treatment of aging. We can generate molecules with specifi...
Interview with Dr. Alex Zhavoronkov, CEO of Insilico Medicine Company awarded the ‘Most Promisin...
Insilico Medicine applying big data analytics to extend healthy longevity. pursuing internal dru...
Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.
AI could cut preclinical drug development time by half, but rigorous trials are crucial
Collaboration among stakeholders can transform public health into public health longevity